Pat Andrews

Board of Directors @Glenmark Pharmaceuticals

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2025 — Present

Board of Directors @Glenmark Pharmaceuticals

View department →

EDUCATION

N/A

Brown University

Bachelor of Arts - BA

N/A

University of Michigan

Master of Business Administration - MBA

SKILLS

ManagementOncologyBiotechnologyLife SciencesSales EffectivenessManaged CareStrategic PlanningLifesciencesCross-Functional Team LeadershipProduct LaunchPharmaceutical IndustryPharmaceutical Sales

ABOUT PAT ANDREWS

Pat Andrews is a public company director and accomplished CEO with a history of transformative leadership in diverse pharmaceutical companies. A strategic executive with an especially broad functional background, Pat is an effective champion of biopharma companies with clinical stage compounds created from leading-edge science. She has launched successful products in the US and through partners in Europe and Asia, led and negotiated complex licensing and partnership agreements, and assembled and inspired high-performance teams around the world. A six-year Director and Member of the Audit Committee at GlycoMimetics (Nasdaq: GLYC), Pat has been a key voice on strategy, resource allocation, and funding decisions as the biotech navigates its first Phase trials, prepares for commercialization, and advances its early-stage portfolio.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.